Stable sub-100 nm PDMS nanoparticles as an intracellular drug delivery vehicle
Copyright © 2020 Elsevier B.V. All rights reserved..
For the past few decades, polydimethylsiloxane (PDMS) elastomer has been used in plethora of biomedical applications. However, PDMS has not much been explored for intracellular drug delivery since the preparation of sub-100 nm particles, preferred for such kind of applications is extremely difficult owing to its innate nature to form a film. In this work, we have performed molecular dynamics (MD) simulation for developing a strategy to restrict the inherent film-forming tendency of PDMS for obtaining stable sub-100 nm PDMS nanoparticles. MD simulation results suggest that introduction of hydroxyl groups on the surface of PDMS improves its stability in the form of nanoparticles. Based on the MD simulation results, for the first time, sub-100 nm PDMS nanoparticles are prepared via in situ surface modification of PDMS with sodium hydroxide inside nanoemulsion droplets. The synthesized nanoparticles are 30-40 nm in size, extremely soft in nature, moderately hydrophobic and stable in phosphate buffered saline. In vitro results demonstrate the synthesized PDMS nanoparticles to possess excellent biocompatibility and an intrinsic capability of selective localization in mitochondria of cancer cells. Furthermore, efficient mitochondrial delivery of anticancer drug doxorubicin through PDMS nanoparticles advocates for their suitability as a potential candidate for developing advanced nanomedicine.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:119 |
|---|---|
| Enthalten in: |
Materials science & engineering. C, Materials for biological applications - 119(2021) vom: 15. Feb., Seite 111577 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Maparu, Auhin Kumar [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
80168379AG |
|---|
| Anmerkungen: |
Date Completed 14.05.2021 Date Revised 14.05.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.msec.2020.111577 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM318867621 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318867621 | ||
| 003 | DE-627 | ||
| 005 | 20231225170245.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.msec.2020.111577 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1062.xml |
| 035 | |a (DE-627)NLM318867621 | ||
| 035 | |a (NLM)33321623 | ||
| 035 | |a (PII)S0928-4931(20)33495-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Maparu, Auhin Kumar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Stable sub-100 nm PDMS nanoparticles as an intracellular drug delivery vehicle |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.05.2021 | ||
| 500 | |a Date Revised 14.05.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier B.V. All rights reserved. | ||
| 520 | |a For the past few decades, polydimethylsiloxane (PDMS) elastomer has been used in plethora of biomedical applications. However, PDMS has not much been explored for intracellular drug delivery since the preparation of sub-100 nm particles, preferred for such kind of applications is extremely difficult owing to its innate nature to form a film. In this work, we have performed molecular dynamics (MD) simulation for developing a strategy to restrict the inherent film-forming tendency of PDMS for obtaining stable sub-100 nm PDMS nanoparticles. MD simulation results suggest that introduction of hydroxyl groups on the surface of PDMS improves its stability in the form of nanoparticles. Based on the MD simulation results, for the first time, sub-100 nm PDMS nanoparticles are prepared via in situ surface modification of PDMS with sodium hydroxide inside nanoemulsion droplets. The synthesized nanoparticles are 30-40 nm in size, extremely soft in nature, moderately hydrophobic and stable in phosphate buffered saline. In vitro results demonstrate the synthesized PDMS nanoparticles to possess excellent biocompatibility and an intrinsic capability of selective localization in mitochondria of cancer cells. Furthermore, efficient mitochondrial delivery of anticancer drug doxorubicin through PDMS nanoparticles advocates for their suitability as a potential candidate for developing advanced nanomedicine | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Doxorubicin | |
| 650 | 4 | |a Intracellular drug delivery | |
| 650 | 4 | |a Molecular dynamics simulation | |
| 650 | 4 | |a Nanoemulsion | |
| 650 | 4 | |a PDMS nanoparticles | |
| 650 | 7 | |a Dimethylpolysiloxanes |2 NLM | |
| 650 | 7 | |a Excipients |2 NLM | |
| 650 | 7 | |a Doxorubicin |2 NLM | |
| 650 | 7 | |a 80168379AG |2 NLM | |
| 700 | 1 | |a Singh, Prerana |e verfasserin |4 aut | |
| 700 | 1 | |a Rai, Beena |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Ashutosh |e verfasserin |4 aut | |
| 700 | 1 | |a Sivakumar, Sri |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Materials science & engineering. C, Materials for biological applications |d 2008 |g 119(2021) vom: 15. Feb., Seite 111577 |w (DE-627)NLM207175020 |x 1873-0191 |7 nnns |
| 773 | 1 | 8 | |g volume:119 |g year:2021 |g day:15 |g month:02 |g pages:111577 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.msec.2020.111577 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 119 |j 2021 |b 15 |c 02 |h 111577 | ||